{"id":66303,"date":"2025-07-02T04:34:03","date_gmt":"2025-07-02T04:34:03","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=66303"},"modified":"2025-07-02T04:34:03","modified_gmt":"2025-07-02T04:34:03","slug":"trending-stocks-by-analysts-for-this-week","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/","title":{"rendered":"Trending Stocks By Analyst’s for this Week"},"content":{"rendered":"

Analyst Ratings (USA)<\/a><\/h3>\n

Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00.
\nAbbVie received a Buy rating from Morgan Stanley, with a price target of $250.00.
\nAemetis had its target raised by UBS Group, reaffirming a Buy rating and lifting the price from $2.20 to $3.00.
\nAeroVironment was initiated with a Buy rating by The Goldman Sachs Group, targeting $301.00.
\nAffirm had its target raised by Barclays and maintained an Overweight rating, with the price increased from $67.00 to $80.00.
\nAgnico Eagle Mines received an Outperform initiation from Raymond James Financial, with a target price of $130.00.
\nAgree Realty was reiterated as Market Perform by JMP Securities.
\nAir Products and Chemicals was reiterated with a Buy rating by Citigroup, increasing the target from $310.00 to $320.00.
\nAlnylam Pharmaceuticals had its target raised by Wells Fargo & Company, maintaining an Equal Weight rating, and the price increased from $287.00 to $333.00.
\nAmerican Healthcare REIT was initiated at Sector Outperform by Scotiabank, with a target of $42.00.
\nAmgen received a Buy rating from TD Cowen, with a price target of $389.00.
\nAmgen was rated Hold by Morgan Stanley, with a target of $330.00.
\nAmplify Energy was initiated with a Buy rating by Alliance Global Partners, with a price target of $6.00.
\nAnglogold Ashanti PLC received a Buy rating from Roth MKM, with a target price of $54.00.
\nAntero Resources was rated Hold by Citi, with a target of $45.00.
\nAramark was maintained at Equal Weight by Morgan Stanley, with a price target increase from $42.00 to $44.00.
\nArgenx Se also received a Buy rating from Wells Fargo, targeting $741.00.
\nArgenx Se was rated Buy by Citi, with a target price of $803.00.
\nARM had its target raised by Guggenheim, keeping a Buy rating and lifting the price from $147.00 to $187.00.
\nAurinia Pharmaceuticals was rated Buy by both Leerink Partners and TD Cowen, with targets of $10.00 and $11.00, respectively.
\nAytu BioPharma was given a Buy initiation by Ascendiant Capital Markets, with a target price of $12.00.
\nB2Gold was initiated with an Outperform rating by Raymond James Financial, targeting $4.50.
\nBaker Hughes Company was rated Buy by Wells Fargo, aiming for $50.00.
\nBeazer Homes USA was initiated as Neutral by B. Riley, with a target of $23.00.
\nBioCryst Pharmaceuticals had its Outperform rating reiterated by Royal Bank of Canada, with a target of $13.00.
\nBioCryst received a Buy rating from BofA Securities, with a target of $15.00.
\nBoeing was rated Buy by Citi, with a price target of $220.00.
\nBoyd Gaming had its Outperform rating reaffirmed by Raymond James Financial, and its target raised from $81.00 to $85.00.
\nBridgeBio Pharma had its target raised by Wells Fargo & Company, keeping an Overweight rating and raising the price from $67.00 to $76.00.
\nBridgeBio Pharma received a Buy rating from Raymond James, with a price target of $57.00.
\nBrookfield Asset Management was initiated with a Neutral rating by Piper Sandler, targeting $60.00.
\nCAE was initiated with a Buy rating by The Goldman Sachs Group, with a target of $33.00.
\nCandel Therapeutics received a Buy initiation from HC Wainwright, targeting $23.00.
\nCapricor Therapeutics was initiated at Buy by Alliance Global Partners, with a price target of $20.00.
\nCarMax received a Buy rating from Morgan Stanley, with a price target of $80.00.
\nCelcuity had its Buy rating reiterated by Needham & Company LLC, with a target of $29.00.
\nCelcuity received a Buy rating from LifeSci Capital, with a target of $27.00.
\nCencora was rated Hold by Jefferies Financial Group, with a raised target of $300.00.
\nCentury Communities was initiated with a Buy rating by B. Riley, targeting $70.00.
\nChemed had its Buy rating maintained by Bank of America, though the price target was lowered from $708.00 to $650.00.
\nCidara Therapeutics had its Market Outperform rating reiterated by JMP Securities, with a target of $59.00.
\nCircle Internet Group was rated Buy by Canaccord Genuity Group, with a target price of $247.00.
\nCircle Internet Group was rated Buy by Citigroup, with a target price of $243.00.
\nCircle Internet Group was rated Buy by Needham & Company LLC, with a target price of $250.00.
\nCircle Internet Group was rated Hold by Deutsche Bank Aktiengesellschaft, with a target price of $155.00.
\nCircle Internet Group was rated Market Perform by Oppenheimer (no price target provided).
\nCircle Internet Group was rated Neutral by The Goldman Sachs Group, with a target price of $83.00.
\nCircle Internet Group was rated Outperform by Sanford C. Bernstein, with a target price of $230.00.
\nCircle Internet Group was rated Overweight by Barclays, with a target price of $215.00.
\nCircle Internet Group was rated Underweight by JPMorgan Chase & Co., with a target price of $80.00.
\nCitius Pharmaceuticals was rated Buy by D. Boral Capital, with a target of $6.00.
\nClene was rated Buy by D. Boral Capital, with a target price of $23.00.
\nCloudastructure received a Buy rating from Maxim Group, targeting $6.00.
\nCoeur Mining was rated Buy by Roth MKM, with a target price of $12.00.
\nCogent Biosciences was rated Neutral by Wedbush, targeting $10.00.
\nCohen & Steers was initiated with an Underperform rating by Bank of America, targeting $67.00.
\nComfort Systems USA was rated Buy by DA Davidson, and the price target was raised to $630.00.
\nConcentrix was rated Buy by Canaccord Genuity Group, with a price target of $80.00.
\nConsolidated Edison was upgraded to Outperform by Mizuho, with a target of $107.00.
\nCoreCivic received a Buy rating from Texas Capital Securities, targeting $28.00.
\nCorMedix was downgraded to Hold by D. Boral Capital (no new price target provided).
\nCrocs was rated Buy by Bank of America, with a reduced target of $135.00.
\nCVS Health was rated Buy by Jefferies Financial Group, with a new target of $80.00.
\nDave was rated Buy by Benchmark, with a raised price target of $320.00.
\nDayforce was rated Buy by Needham & Company LLC, targeting $95.00.
\nDelek US was rated Outperform by Raymond James Financial, with a price target of $23.00.
\nDianthus Therapeutics was assigned a Buy rating by LifeSci Capital, with a target of $45.00.
\nDoorDash was rated Outperform by Oppenheimer, targeting $280.00.
\nDriven Brands was initiated as Buy by BTIG Research, targeting $22.00.
\nDuolingo was rated Buy by Evercore ISI, targeting $540.00.
\nDutch Bros was initiated as Outperform by CICC Research, targeting $80.00.
\neBay was rated Equal Weight by Wells Fargo & Company, with a new target of $66.00.
\nEdgewise Therapeutics was initiated with a Buy rating by HC Wainwright, with a price target of $42.00.
\nEmerson Electric Company received a Buy rating from KeyBanc, with a price target of $155.00.
\nEtsy was rated Underweight by Wells Fargo & Company, with a raised target of $41.00.
\nExelixis was rated Buy by HC Wainwright, with a revised target of $53.00.
\nExpand Energy also received a Buy rating from Mizuho Securities, with a target of $142.00.
\nExpand Energy received a Buy rating from Citi, targeting $140.00.
\nExpeditors International of Washington was rated Hold by Truist Financial, with a revised target of $110.00.
\nExpro Group Holdings received a Buy rating from Wells Fargo, with a target price of $12.00.
\nFabrinet was rated Buy by Fox Advisors, with a target of $335.00.
\nFederal Signal was rated Outperform by Raymond James Financial, with a raised target of $120.00.
\nFirst Busey was initiated as Market Perform by Hovde Group, with a target of $25.00.
\nFirst Solar received a Buy rating from Wells Fargo, with a price target of $177.00.
\nFrequency Electronics received a Buy rating from Freedom Capital Markets, targeting $27.00.
\nFulcrum Therapeutics was rated Sell by BofA Securities, with a price target of $6.00.
\nGain Therapeutics received a Buy rating from BTIG, with a price target of $10.00.
\nGain Therapeutics was rated Buy by Roth MKM, with a target price of $7.00.
\nGeneDx was rated Buy by Guggenheim, with an increased target of $115.00.
\nGenius Sports was rated Market Outperform by JMP Securities, with a raised price target of $13.00.
\nGenpact received a Buy rating from Needham & Company LLC, targeting $50.00.
\nGeo Group was also rated Buy by Texas Capital Securities, with a target of $30.00.
\nGreen Brick Partners was initiated with a Neutral rating by B. Riley, with a target of $62.00.
\nGrindr received a Market Outperform rating from JMP Securities, with a raised target of $27.00.
\nGuaranty Bancshares was rated Overweight by Stephens, targeting $47.00.
\nGXO Logistics was rated Hold by Truist Financial, with a revised target of $48.00.
\nHewlett Packard Enterprise received a Buy rating from Bank of America, with a raised target of $23.00.
\nHippo Holdings was rated Buy by B.Riley Financial, with a price target of $35.00.
\nHome Depot received a Buy rating from Citi, aiming for $433.00.
\nHome Depot received a Buy rating from Wells Fargo, with a price target of $420.00.
\nHome Depot was rated Outperform by Telsey Advisory Group, targeting $455.00.
\nHowmet Aerospace was rated Outperform by Royal Bank Of Canada.
\nHyatt Hotels also received a Buy rating from BofA Securities, targeting $150.00.
\nHyatt Hotels received a Hold rating from Morgan Stanley, targeting $132.00.
\nHyatt Hotels was rated Buy by Bernstein, targeting $167.00.
\nIamgold was initiated with a Market Perform rating by Raymond James Financial, targeting $8.00.
\nIndivior was rated Buy by Craig Hallum, with a raised target of $22.00.
\nInmune Bio was rated Hold by BTIG, with a price target of $21.00.
\nInuvo received a Buy rating from HC Wainwright, with a target raised to $15.00.
\nIonis Pharmaceuticals was rated Buy by Barclays, targeting $57.00.
\nIt also received a target raise from Wedbush, maintaining the Outperform rating and increasing the price from $16.00 to $18.00.
\nJ.B. Hunt Transport Services was rated Hold by Truist Financial, with a new price target of $140.00.
\nJoby Aviation was rated Buy by Canaccord Genuity, with a target of $12.00.
\nKB Home received a Sell rating from CFRA, with a price target of $49.00.
\nKellanova received a Hold rating from TD Cowen, with a price target of $83.50.
\nKinross Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $15.00.
\nKKR & Co. Inc. was initiated with an Overweight rating by Piper Sandler, targeting $150.00.
\nKratos Defense & Security Solutions was upgraded to Buy by The Goldman Sachs Group, targeting $52.00.
\nKrystal Biotech was rated Buy by Clear Street, with a target of $190.00.
\nLargo received a Buy rating from HC Wainwright, targeting $3.70.
\nLear was rated Buy by Citigroup, with a raised target of $136.00.
\nLeonardo DRS was initiated as Buy by The Goldman Sachs Group, with a target of $49.00.
\nLinde was upgraded to Buy by Citigroup, with a raised target of $535.00.
\nM&T Bank was assigned a Buy rating by RBC Capital, with a target of $200.00.
\nMarathon Petroleum was rated Strong-Buy by Raymond James Financial, with a raised target of $188.00.
\nMasTec was rated Buy by Roth MKM, with a target of $210.00.
\nMcDonald’s was rated Overweight by KeyCorp, with a revised price target of $325.00.
\nMcEwen Mining received a Buy rating from Roth MKM, with a target of $15.00.
\nMedical Properties Trust was rated Sector Perform by Royal Bank Of Canada, with a lowered target of $4.50.
\nMedtronic was upgraded to Peer Perform by Wolfe Research.
\nMicrosoft was reiterated with a Positive rating by UBS Group.
\nMister Car Wash was initiated with a Neutral rating by BTIG Research.
\nModerna received a Hold rating from Morgan Stanley, targeting $31.00.
\nNeogen was rated Buy by Guggenheim, with a revised target of $10.00.
\nNew Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $4.00.
\nNorwegian Cruise Line was rated Neutral by UBS Group, with a reduced price target of $23.00.
\nNOV also received a Hold rating from Citi, targeting $13.00.
\nNOV was rated Sell by Wells Fargo, with a target of $10.00.
\nNU received an Overweight rating from JPMorgan Chase & Co., with a raised target of $16.00.
\nNuvalent was rated Buy by Goldman Sachs, targeting $105.00.
\nOld Dominion Freight Line was rated Buy by Truist Financial, with an updated target of $180.00.
\nOmeros received a Buy rating from D. Boral Capital, targeting $36.00.
\nOmnicell was rated Buy by Wells Fargo, with a target of $37.00.
\nOracle also received a Buy rating from TD Cowen, targeting $250.00.
\nOracle received a Buy rating from Deutsche Bank, with a target of $240.00.
\nOracle was upgraded to Buy by Stifel Nicolaus, with a target raised to $250.00.
\nOS Therapies was rated Buy by D. Boral Capital, with a target of $20.00.
\nPalomar was rated Outperform by Keefe, Bruyette & Woods, with a revised target of $204.00.
\nPar Pacific received an Outperform rating from Raymond James Financial, with a raised price target of $30.00.
\nParker Hannifin received a Buy rating from BofA Securities, with a target of $715.00.
\nPegasystems was rated Buy by Loop Capital, with an increased price target of $60.00.
\nPlanet Labs PBC was initiated with a Neutral rating by The Goldman Sachs Group, targeting $4.60.
\nPNC Financial received a Buy rating from RBC Capital, aiming for $195.00.
\nPorch Group received a Buy rating from B.Riley Financial, targeting $15.00.
\nProKidney was downgraded to Underperform by Bank of America, with a lowered target of $1.00.
\nProtagonist Therapeutics received a Buy rating from Citi, with a price target of $72.00.
\nQorvo was also rated Hold by Mizuho Securities, targeting $84.00.
\nRegeneron Pharmaceuticals was downgraded to Hold by Argus.
\nRobinhood Markets received a Buy rating from KeyBanc, targeting $110.00.
\nRobinhood Markets was rated Buy by Barclays, targeting $57.00.
\nRoblox received an Overweight rating from JPMorgan Chase & Co., with a raised target of $120.00.
\nRocket Lab was initiated with a Neutral rating by The Goldman Sachs Group, targeting $27.00.
\nRocket Pharmaceuticals received a Hold rating from Morgan Stanley, with a target of $7.00.
\nSailPoint was initiated with an Overweight rating by Cantor Fitzgerald, targeting $29.00.
\nSchlumberger received an Overweight rating from JPMorgan Chase & Co., with a lowered target of $44.00.
\nSchlumberger was rated Buy by Wells Fargo, targeting $43.00.
\nSEI Investments was rated Outperform by Oppenheimer, with a raised target of $96.00.
\nSharkNinja, Inc. was rated Buy by Jefferies, with a target of $175.00.
\nSkyworks Solutions received a Hold rating from Mizuho Securities, with a target of $75.00.
\nSmurfit Westrock received an Overweight rating from Barclays, with a slightly lowered target of $63.00.
\nSouthern Copper received a Hold rating from UBS, with a price target of $105.00.
\nStarbucks was initiated with an Outperform rating by CICC Research, targeting $100.00.
\nStevanato Group was reiterated as Outperform by William Blair.
\nStrategy was rated Buy by TD Cowen, targeting $590.00.
\nSummit Therapeutics received a Buy rating from UBS, with a target of $30.00.
\nSynopsys received a Hold rating from Wells Fargo, with a price target of $520.00.
\nTD SYNNEX was rated Buy by Loop Capital, with an increased target of $160.00.
\nTempus AI was rated Buy by Guggenheim, with a raised target of $75.00.
\nTesla received a Buy rating from Deutsche Bank, with a price target of $345.00.
\nTesla was rated Buy by Morgan Stanley, with a price target of $410.00.
\nTesla was reiterated as Buy by Canaccord Genuity Group, with a target of $303.00.
\nTransdigm Group was rated Buy by BofA Securities, with a price target of $1,615.00.
\nTronox was downgraded to Underperform by BMO Capital Markets, with a reduced target of $3.00.
\nTyra Bioscience was rated Buy by Oppenheimer, targeting $30.00.
\nUnifirst received a target price of $197.00 set by Robert W. Baird.
\nUnifirst was rated Underweight by Barclays, with a price target of $152.00.
\nUnifirst was reiterated as Neutral by UBS Group.
\nUnited Therapeutics was rated Buy by UBS Group, with a lowered target of $385.00.
\nUS Bancorp was rated Buy by RBC Capital, with a price target of $50.00.
\nUS Gold was assigned a Buy rating by Roth MKM, aiming for $18.00.
\nValero Energy was rated Strong-Buy by Raymond James Financial, with a raised target of $155.00.
\nVipshop received an Overweight rating from JPMorgan Chase & Co., with a decreased target of $18.00.
\nVipshop was given a Hold rating by Citi, with a target of $17.00.
\nVirgin Galactic was initiated with a Neutral rating by The Goldman Sachs Group, targeting $3.00.
\nVor Biopharma was upgraded to Buy by HC Wainwright, targeting $3.00.
\nWabash National received a Hold rating from D.A. Davidson, with a target of $9.50.
\nWalt Disney was upgraded to Buy by Jefferies Financial Group, with a target of $144.00.
\nWaystar was initiated with an Outperform rating by Mizuho, targeting $48.00.
\nWhirlpool was upgraded to Buy by Longbow Research, targeting $145.00.
\nWingstop was rated Buy by BTIG, with a target of $430.00.
\nWinnebago Industries was rated Buy by Benchmark, with a reduced price target of $42.00.
\nXPO was rated Buy by Truist Financial, with a raised target of $135.00.
\nZai Lab received an Outperform rating from Leerink Partners, with a revised target of $75.00.
\nZai Lab was assigned a Buy rating by Citi, with a target of $66.00.
\nZai Lab was rated Buy by Leerink Partners, with a price target of $75.00.
\nZynex was reiterated as Buy by HC Wainwright, targeting $8.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating from Morgan Stanley,…<\/p>\n","protected":false},"author":3,"featured_media":4491,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66303","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nTrending Stocks By Analyst's for this Week | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trending Stocks By Analyst's for this Week\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating from Morgan Stanley,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-02T04:34:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2021\/02\/starbucks.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Trending Stocks By Analyst’s for this Week\",\"datePublished\":\"2025-07-02T04:34:03+00:00\",\"dateModified\":\"2025-07-02T04:34:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\"},\"wordCount\":2643,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\",\"name\":\"Trending Stocks By Analyst's for this Week | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2025-07-02T04:34:03+00:00\",\"dateModified\":\"2025-07-02T04:34:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trending Stocks By Analyst’s for this Week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Trending Stocks By Analyst's for this Week | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/","og_locale":"en_US","og_type":"article","og_title":"Trending Stocks By Analyst's for this Week","og_description":"Analyst Ratings (USA) Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating from Morgan Stanley,...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2025-07-02T04:34:03+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2021\/02\/starbucks.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Trending Stocks By Analyst’s for this Week","datePublished":"2025-07-02T04:34:03+00:00","dateModified":"2025-07-02T04:34:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/"},"wordCount":2643,"commentCount":2,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/","name":"Trending Stocks By Analyst's for this Week | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2025-07-02T04:34:03+00:00","dateModified":"2025-07-02T04:34:03+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/trending-stocks-by-analysts-for-this-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Trending Stocks By Analyst’s for this Week"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=66303"}],"version-history":[{"count":2,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66303\/revisions"}],"predecessor-version":[{"id":66306,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66303\/revisions\/66306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/4491"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=66303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=66303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=66303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}